| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2014 | Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence | CHUN-JEN LIU ; Chang J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. | World Journal of Gastroenterology | 43 | ||
| 2014 | Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence | Liu C.-J.; Chang J.; PO-HUANG LEE ; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. | World Journal of Gastroenterology | 43 | ||
| 2014 | Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence | Liu C.-J.; Chang J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; REY-HENG HU ; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. | World Journal of Gastroenterology | 41 | 43 | |
| 2014 | Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence | Liu C.-J.; Chang J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; MING-CHIH HO ; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. | World Journal of Gastroenterology | 41 | 43 | |
| 2014 | Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence | Liu C.-J.; Chang J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN | World Journal of Gastroenterology | 43 | ||
| 2015 | Asunaprevir-containing regimens for the treatment of hepatitis C virus infection | Yang S.-S.; JIA-HORNG KAO | Expert Review of Gastroenterology and Hepatology | 5 | ||
| 2013 | Biphasic pattern of depression and its predictors during pegylated interferon-based therapy in chronic hepatitis B and C patients | Huang Y.-W.; Hu J.-T.; Hu F.-C.; Chang C.-J.; Chang H.-Y.; JIA-HORNG KAO ; Yang S.-S.; Chen D.-S. | Antiviral Therapy | 8 | ||
| 2006 | Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C | Yang S.-S.; Fu L.-S.; Chang C.-S.; Yeh H.-Z.; Chen G.-H.; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 17 | ||
| 2011 | Classification of PICO elements by text features systematically extracted from PubMed abstracts | Huang K.-C.; Liu C.C.-H.; Yang S.-S.; FU-REN XIAO ; Wong J.-M.; Liao C.-C.; Chiang I.-J. | Proceedings - 2011 IEEE International Conference on Granular Computing, GrC 2011 | 5 | 0 | |
| 2016 | Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection | Yang S.-S.; JIA-HORNG KAO | Hepatology International | 8 | ||
| 2009 | Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: A 20-year follow-up study | Chang M.-H.; You S.-L.; Chen C.-J.; CHUN-JEN LIU ; Lee C.-M.; Lin S.-M.; Chu H.-C.; Wu T.-C.; Yang S.-S.; Kuo H.-S.; Chen D.-S. | Journal of the National Cancer Institute | 380 | ||
| 2009 | Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: A 20-year follow-up study | MEI-HWEI CHANG ; You S.-L.; Chen C.-J.; Liu C.-J.; Lee C.-M.; Lin S.-M.; Chu H.-C.; Wu T.-C.; Yang S.-S.; Kuo H.-S.; Chen D.-S. | Journal of the National Cancer Institute | 383 | ||
| 2010 | Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B | Huang Y.-W.; Chayama K.; Tsuge M.; Takahashi S.; Hatakeyama T.; Abe H.; Hu J.-T.; Liu C.-J.; Lai M.-Y.; Chen D.-S.; Yang S.-S.; JIA-HORNG KAO | Antiviral Therapy | 37 | ||
| 2010 | Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B | Huang Y.-W.; Chayama K.; Tsuge M.; Takahashi S.; Hatakeyama T.; Abe H.; Hu J.-T.; CHUN-JEN LIU ; Lai M.-Y.; Chen D.-S.; Yang S.-S.; Kao J.-H. | Antiviral Therapy | 37 | ||
| 2006 | Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients | CHIEN-HUNG CHEN ; Chang T.-T.; Cheng K.-S.; Su W.-W.; Yang S.-S.; Lin H.H.; Wu S.-S.; Lee C.-M.; Changchien C.-S.; Chen C.-J.; Sheu J.-C.; Chen D.-S.; Lu S.-N. | Liver International | 58 | 52 | |
| 2021 | Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in Taiwan | Hong C.-M.; Lin Y.-Y.; CHUN-JEN LIU ; Lai Y.-Y.; Yeh S.-H.; Yang H.-C.; Kao J.-H.; Hsu S.-J.; Huang Y.-H.; Yang S.-S.; Kuo H.-T.; Cheng P.-N.; Yu M.-L.; Chen P.-J. | Viruses | 0 | ||
| 2011 | Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy | Tseng T.-C.; Yu M.-L.; Liu C.-J.; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; Liu C.-H.; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO | Antiviral Therapy | 69 | ||
| 2011 | Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy | Tseng T.-C.; Yu M.-L.; CHUN-JEN LIU ; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; Liu C.-H.; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; Chen P.-J.; Chen D.-S.; Kao J.-H. | Antiviral Therapy | 69 | ||
| 2011 | Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy | Tseng T.-C.; Yu M.-L.; Liu C.-J.; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; CHEN-HUA LIU ; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; Chen P.-J.; Chen D.-S.; Kao J.-H. | Antiviral Therapy | 69 | ||
| 2011 | Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy | Tseng T.-C.; Yu M.-L.; Liu C.-J.; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; Liu C.-H.; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; PEI-JER CHEN ; Chen D.-S.; Kao J.-H. | Antiviral Therapy | 69 |
